Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Boehringer Ingelheim
Merck
Moodys
McKinsey

Last Updated: August 19, 2022

Investigational Drug Information for Psilocybin


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Psilocybin?

Psilocybin is an investigational drug.

There have been 104 clinical trials for Psilocybin. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2022.

The most common disease conditions in clinical trials are Depression, Depressive Disorder, and Disease. The leading clinical trial sponsors are Johns Hopkins University, Heffter Research Institute, and COMPASS Pathways.

There are seven hundred and twenty-nine US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Psilocybin
TitleSponsorPhase
Effects of Repeated Psilocybin Dosing in OCDSteven & Alexandra Cohen FoundationPhase 1
Effects of Repeated Psilocybin Dosing in OCDYale UniversityPhase 1
Psilocybin Therapy in Advanced CancerNational Cancer Institute (NCI)Phase 2/Phase 3

See all Psilocybin clinical trials

Clinical Trial Summary for Psilocybin

Top disease conditions for Psilocybin
Top clinical trial sponsors for Psilocybin

See all Psilocybin clinical trials

US Patents for Psilocybin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Psilocybin See Plans and Pricing Devices and methods for continuous analyte monitoring DexCom, Inc. (San Diego, CA) See Plans and Pricing
Psilocybin See Plans and Pricing Devices and methods for continuous analyte monitoring DexCom, Inc. (San Diego, CA) See Plans and Pricing
Psilocybin See Plans and Pricing Indicator and analytics for sensor insertion in a continuous analyte monitoring system and related methods DexCom, Inc. (San Diego, CA) See Plans and Pricing
Psilocybin See Plans and Pricing Advanced analyte sensor calibration and error detection DexCom, Inc. (San Diego, CA) See Plans and Pricing
Psilocybin See Plans and Pricing Drug device configured for wireless communication Pop Test Abuse Deterrent Technology, LLC (Cliffside Park, NJ) See Plans and Pricing
Psilocybin See Plans and Pricing Personal substance detection field test kit Lindon Group, Inc. (East Providence, RI) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Psilocybin

Drugname Country Document Number Estimated Expiration Related US Patent
Psilocybin Denmark DK3069279 2033-11-14 See Plans and Pricing
Psilocybin European Patent Office EP3069279 2033-11-14 See Plans and Pricing
Psilocybin European Patent Office EP3796332 2033-11-14 See Plans and Pricing
Psilocybin World Intellectual Property Organization (WIPO) WO2015073459 2033-11-14 See Plans and Pricing
Psilocybin Denmark DK3069279 2033-11-14 See Plans and Pricing
Psilocybin European Patent Office EP3069279 2033-11-14 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Boehringer Ingelheim
Merck
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.